Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the LightPath® Imaging System and the PET Tracer 68Ga-RM2 in Wide Local Excision (WLE) for Breast Cancer

NCT03731026 is registered in ClinicalTrials.gov with Lightpoint Medical Limited as lead sponsor.

NCT NCT03731026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03731026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the LightPath® Imaging System and the PET Tracer 68Ga-RM2 in Wide Local Excision (WLE) for Breast Cancer
Lead sponsor
Lightpoint Medical Limited
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2018
Completion date
November 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer